🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today, we’re introducing our new five-year strategy: Finding breakthroughs. Giving hope. Saving Lives. Pancreatic cancer is the toughest of cancer challenges. But in the last 5 years, thanks to our dedicated supporters, we have seen more progress than in the previous 5 decades.

Great seminar & institute visit day yesterday at Microbiome Signatures Universität München. Many thanks for the invitation, insightful discussions and taste of bavarian culture/beer Saur Lab Christian Braun and Maximilian Reichert!

Honored to have delivered a talk at Munich's translaTUM and excited to kick off our collaboration with Saur Lab on pancreatic cancer treatment, supported by #DKFZ and Israel MOST grant. Thank you for organizing such a wonderful and productive visit

Excited that veloVI is out Nature Methods! Led by Adam Gayoso & Philipp Weiler w awesome Yosef Lab, we combine deep generative modeling with a mechanistic single-cell transcriptional model for better RNA velocity analysis with uncertainty quantification. nature.com/articles/s4159…

A great day visiting TU München, a place for awesome science - and the shape of the TranslaTUM reflects it :) Thanks for hosting Saur Lab and #RolandRad!

Fantastic talk and great insights by Chiara Falcomatà at the #Cancer #Immunotherapy conference #CICON23 hosted by Cancer Research Institute ENCI and AACR on the mechanisms of cancer cell elicited immunosuppression in #PancreaticCancer.

🗣️Don't miss this ☑️Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models 🔗buff.ly/49zv1SA #Carfilzomib #CRCsm #ERstress #BRAF

Nature Cancer publishes our work (nature.com/articles/s4301…) and Cancer Discovery publishes a 'Research Watch' note about this work (aacrjournals.org/cdnews/news/12…). Feels gratifying to see that this important piece of work is appreciated by the community. Not a trivial story, but worth reading.

Delighted to share our latest culinary adventure at the international #SaurLabDinner featuring delectable Lebanese cuisine! Huge thanks to Frederic for orchestrating such a mouthwatering experience. Can't wait for the next culinary adventure! 🍽🌍

Now published in the Sept. 5 issue of Cell: A holistic view of the vascular endothelium as a systemically disseminated organ. Go to cell.com/cell/fulltext/… if you want to learn more about the beauty and importance of endothelial cells in health and disease.

“There are not, and will never be, KRAS inhibitors” 👀 PascaLab presents a memorable reviewer comment from her 1st unfunded NIH grant at #AACRPan24. The lesson is that you should not let deflating reviewer comments define the value of your science. Also, persistence!

Was für ein sensationelles Benefizkonzert von A. S. Mutter für die ⁦Deutsche Krebshilfe⁩ Vielen Dank für den wunderbaren Abend!

First clinical data of Revolution Medicines KRAS G12D inhibitor RMC-9805 in #PancreaticCancer presented by David S. Hong MD MD Anderson Cancer Center globenewswire.com/en/news-releas… 30% objective response rate, 80% disease control rate at 1200mg daily dose. #ENA2024

Had a truly inspiring experience at the @BottonChampalimaud #PancreaticCancer Conference - reconnected with friends and colleagues, to advance pancreatic cancer research and patient care. Anirban Maitra Ben Stanger Saur Lab and many more... Reichert Lab

Grateful for the continued support of Cancer Research Institute and its inspiring community! Excited to share my journey and enthusiasm in this video: youtu.be/Piihfjuuet0 Lipschultz Precision Immunology Institute

"The funding from CRI has been fundamental. It has enabled all of the work that I've been doing so far," CRI Postdoctoral Fellow Dr. Chiara Falcomatà Icahn School of Medicine at Mount Sinai shares. Discover how CRI-funded researchers are accelerating impact in cancer research: bit.ly/3YacKHs

We had the amazing opportunity to write about these 4 amazing papers shorturl.at/pAIDr. Hope you enjoy the reading and share! Cancer Discovery, Tuomas Tammela, Ferdinandos Skoulidis, Andy Aguirre and Howard Crawford

Several years in the making (and aging), Xueqian Zhuang 's study on aging is out today nature. She finds, surprisingly, that aging suppresses tumorigenesis and stemness in the lung by promoting a functional iron insufficiency in the alveolar epithelium. nature.com/articles/s4158…

Thrilled to share that our paper nature.com/articles/s4158… is featured in a fantastic Nature News & Views piece by Thomas Tueting! 🎉 Grateful for the spotlight on our research and its impact on understanding cancer immunology. nature.com/articles/d4158… 👀👉 rdcu.be/d3cRz

🚨 Exciting Opportunity for Master’s Students!🚨 We’re looking for two motivated Master’s students to work on #CRISPR screening projects in #PDAC. 📧 Interested? Send your application to: [email protected] We look forward to your application! 🚀